Skip to main content

Table 1 Anthropometric and demographic data of the patient group

From: Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients

Participants Mean (95% CI)
Female/Male 19 (41.3%)/27 (58.7%)
Age (years) at diagnosis 13.9 (13.0 to 14.9)
Age (years) at measurement 14.3 (13.3 to 15.2)
Caucasian 46 (100%)
Height (m)/Z-score 1.64 (1.59 to 1.69)/0.07 (-0.04 to 0.19)
Weight (kg)/Z-score 52.2 (47.5 to 56.9)/-0.31 (-0.51 to -0.10)
BMI (kg/m2)/Z-score 18.9 (17.9 to 20.0)/-1.03 (-1.55 to -0.51) *
Low BMD (Z-score ≤ -1SD) (2 females, 11 males)
Age (years) at measurement 14.8 (13.1 to 16.4)
BMI (kg/m2)/Z-score 18.7 (16.5 to 20.9)/-1.67 (-3.04 to -0.30)
Weight (kg)/Z-score 52.2 (43.7 to 60.7)/-0.68 (-1.24 to -0.12)
Normal BMD (Z-score > -1SD) (17 females, 16 males)
Age (years) at measurement 14.1 (12.9 to 15.3)
BMI (kg/m2)/Z-score 19.0 (17.7 to 20.4)/-0.44 (-0.89 to 0.0)
Weight (kg)/Z-score 52.2 (46.2 to 58.1)/-0.20 (-0.43 to 0.02)
Localisation (Female/Male)
Upper extremity 4 (8.7%)/6 (13.0%) ∑ 10 (21.7%)
Lower extremity 15 (32.6%)/21 (45.7%) ∑ 36 (78.3%)
   Femur/Tibia 12 (26.1%)/17 (37.0) ∑ 29 (63.0%)
   Pelvis/Fibula 3 (6.5%)/4 (8.7%) ∑ 7 (15.2%)
Total 46 (100%)
  1. CI = confidence interval, BMI = body mass index, ∑ = sum, * significant difference between patient group and healthy control group, † significant difference between patients with low BMD (Z-score lumbar spine ≤ -1) and patients with normal BMD status (Z-score lumbar spine > -1)